首页 | 本学科首页   官方微博 | 高级检索  
     


Operational lessons learned in conducting a multi-country collaboration for vaccine safety signal verification and hypothesis testing: The global vaccine safety multi country collaboration initiative
Affiliation:1. Department of Essential Medicines and Health Products, World Health Organization, Geneva, Switzerland;2. International Professional Consultant, World Health Organization, Geneva, Switzerland;3. Center for Global Child Health, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, United States;4. VACCINE.GRID Foundation, Basel, Switzerland;5. Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands;6. Vaccine Research Unit, Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana, FISABIO, Valencia, Spain;7. Unit of Medicines and Health Technologies, Department of Health Systems and Services, Pan American Health Organization (PAHO/WHO), Washington DC, DC, United States;8. Unit of Comprehensive Family Immunization, Department of Family, Gender and Life Course, Pan American Health Organization (PAHO/WHO), Washington DC, DC, United States;9. International Professional Consultant, Pan American Health Organization (PAHO/WHO), Washington DC, DC, United States;10. Utrecht University Medical Center, Julius Global Health, The Netherlands;1. Marshfield Clinic Research Institute, Marshfield, WI, United States;2. Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States;3. School of Public Health, University of California, Berkeley, CA, United States;4. Department of Pediatrics, Duke University School of Medicine, Durham, NC, United States;5. Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY, United States;1. Pediatric Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran;2. Department of Epidemiology and Biostatics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran;3. Department of Microbiology, Iranian Reference Health laboratory Research Center, Ministry of Health and Medical Education, Tehran, Iran;4. Antimicrobial Resistance Center, Iran University of Medical sciences, Tehran, Iran;1. Department of Paediatrics, Dalhousie University, IWK Health Centre, Halifax, Canada;2. Vaccine Supply and Quality, IVD, SEARO, Bangkok, Thailand;3. Epidemiology Unit, Ministry of Health, Colombo, Sri Lanka;4. Safety and Vigilance, Regulation of Medicines and Other Health Technologies, Department of Essential Medicines and Health Products, Health Systems and Innovation, WHO HQ, Geneva, Switzerland;1. Department of Biomedical Sciences, Faculty of Sciences, University of Dschang, Cameroon;2. Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Basel, Switzerland;3. Clinical Research Unit, Division of Health Operations Research, Ministry of Public Health, Cameroon;4. Institute of Social and Preventive Medicine, Faculty of Medicine, University of Geneva, Switzerland;5. Biostatistics Unit, Department of Public Health, Faculty of Medicine & Biomedical Sciences, University of Yaounde I, Cameroon;6. Department of Pharmacology Drugs and Laboratory, Ministry of Public Health, Cameroon;7. Department of Ambulatory Care and Community Medicine–Infectious Disease Service, University Hospital, Lausanne, Switzerland;1. Institute for Global Health, University of Siena, Siena, Italy;2. Department of Community Medicine, Believers Church Medical College, Thiruvalla, Kerala, India;3. Faculty of Pharmacy, Université de Montréal, Montreal, Quebec, Canada;4. Rutgers, The State University of New Jersey, New Brunswick, NJ, USA
Abstract:Timely and effective evaluation of vaccine safety signals for newly developed vaccines introduced in low and middle- income countries (LMICs) is essential. The study tested the development of a global network of hospital-based sentinel sites for vaccine safety signal verification and hypothesis testing. Twenty-six sentinel sites in sixteen countries across all WHO regions participated, and 65% of the sites were from LMIC. We describe the process for the establishment and operationalization of such a network and the lessons learned in conducting a multi-country collaborative initiative. 24 out of the 26 sites successfully contributed data for the global analysis using standardised tools and procedures. Our study successfully confirmed the well-known risk estimates for the outcomes of interest. The main challenges faced by investigators were lack of adequate information in the medical records for case ascertainment and classification, and access to immunization data. The results suggest that sentinel hospitals intending to participate in vaccine safety studies strengthen their systems for discharge diagnosis coding, medical records and linkage to vaccination data. Our study confirms that a multi-country hospital-based network initiative for vaccine safety monitoring is feasible and demonstrates the validity and utility of large collaborative international studies to monitor the safety of new vaccines introduced in LMICs.
Keywords:Post-marketing surveillance  Vaccine safety  Global Vaccine Safety Initiative (GVSI)  Adverse events following immunization (AEFI)  AEFI"  },{"  #name"  :"  keyword"  ,"  $"  :{"  id"  :"  k0030"  },"  $$"  :[{"  #name"  :"  text"  ,"  _"  :"  adverse events following immunization  AM"  },{"  #name"  :"  keyword"  ,"  $"  :{"  id"  :"  k0040"  },"  $$"  :[{"  #name"  :"  text"  ,"  _"  :"  aseptic meningitis  CRF"  },{"  #name"  :"  keyword"  ,"  $"  :{"  id"  :"  k0050"  },"  $$"  :[{"  #name"  :"  text"  ,"  _"  :"  case report form  GVSI"  },{"  #name"  :"  keyword"  ,"  $"  :{"  id"  :"  k0060"  },"  $$"  :[{"  #name"  :"  text"  ,"  _"  :"  Global Vaccine Safety Initiative  ITP"  },{"  #name"  :"  keyword"  ,"  $"  :{"  id"  :"  k0070"  },"  $$"  :[{"  #name"  :"  text"  ,"  _"  :"  immune thrombocytopenic purpura  ERC"  },{"  #name"  :"  keyword"  ,"  $"  :{"  id"  :"  k0080"  },"  $$"  :[{"  #name"  :"  text"  ,"  _"  :"  Ethical Review Committee  GBS"  },{"  #name"  :"  keyword"  ,"  $"  :{"  id"  :"  k0090"  },"  $$"  :[{"  #name"  :"  text"  ,"  _"  :"  Guillain-Barre Syndrome  IRB"  },{"  #name"  :"  keyword"  ,"  $"  :{"  id"  :"  k0100"  },"  $$"  :[{"  #name"  :"  text"  ,"  _"  :"  Institutional Review Board  LMICs"  },{"  #name"  :"  keyword"  ,"  $"  :{"  id"  :"  k0110"  },"  $$"  :[{"  #name"  :"  text"  ,"  _"  :"  low and middle-income countries  PPV"  },{"  #name"  :"  keyword"  ,"  $"  :{"  id"  :"  k0120"  },"  $$"  :[{"  #name"  :"  text"  ,"  _"  :"  positive predictive value  QAC"  },{"  #name"  :"  keyword"  ,"  $"  :{"  id"  :"  k0130"  },"  $$"  :[{"  #name"  :"  text"  ,"  _"  :"  quality assurance committee  SCCS"  },{"  #name"  :"  keyword"  ,"  $"  :{"  id"  :"  k0140"  },"  $$"  :[{"  #name"  :"  text"  ,"  _"  :"  self-controlled case series  WHO"  },{"  #name"  :"  keyword"  ,"  $"  :{"  id"  :"  k0150"  },"  $$"  :[{"  #name"  :"  text"  ,"  _"  :"  World Health Organization
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号